
In part two of the three-part series on writing a strong commercialization plan, NCI SBIR Program Director William Bozza is joined by NCI SBIR-funded, Beatrice Langton-Webster, director and CEO of Cancer Targeted Technology, Madelyn Herzfeld, co-Founder and vice chairman of Carevive Systems, and Carlos Castro-Gonzalez, co-founder and CEO of Leuko Labs, who share insights on this key Phase II SBIR/STTR application component.
SBIR DEVELOPMENT CENTER
SBIR Innovation Lab Podcast: https://sbir.cancer.gov/about/innovation-lab-podcast
SBIR Development Center: https://sbir.cancer.gov/
LEARN MORE FROM THE NATIONAL CANCER INSTITUTE
Online: https://www.cancer.gov
By Phone: 1-800-4-CANCER (1-800-422-6237)
U.S. Department of Health and Human Services
National Institutes of Health
National Cancer Institute
Weitere Episoden von „SBIR Innovation Lab“



Verpasse keine Episode von “SBIR Innovation Lab” und abonniere ihn in der kostenlosen GetPodcast App.








